Treatment of Hepatitis C Infection

Self-StudyTreatment of Hepatitis C Infection

Treatment of Hepatitis C

You are just a few steps away from free CE credits!

Sign in or Register

A free account is required.

Study the Material

An entire Cc section, or just a few topics at a time.

Take the CE Quiz

5 questions covering the topics in each Cc section.

Claim CE Credit

Free CNE and Free CME available!

Your Certificate of Completion

CE (CNE and CME) Certificates CNE/CME

You can earn CNE or CME for each module in this set. For CNE, your certificate will be provided by the University of Washington School of Nursing. For CME, your certificate will be provided by the University of Alabama at Birmingham. Each of these certificates will reflect the number of modules completed.

CE As You Go! You earn CE as you complete each module, and DO NOT have to complete all modules before printing your CE certificate.

Print your CE certificate from the Home screen or one of the modules where you obtained that CE.

Non-CE Certificate

This certificate only shows the self-study modules you complete and does not show continuing education credits.

Complete Lessons

Each Lesson completed will be displayed on your certificate.

Lesson Quiz completion is required with a minimum score of 80%..

0/5lessons
completed

Print Certificate

Your certificate will show your progress thus far.

Self-Study Module Progress Tracker - 4th Edition

	Lesson 1Simplified HCV Treatment for All HCV Genotypes Summarize the eligibility criteria for the American Association for the Study of Liver Disease/Infectious Diseases Society of America (AASLD/IDSA) simplified HCV treatment algorithm Discuss how to assess liver fibrosis, including identifying decompensated cirrhosis List the direct-acting antiviral (DAA) treatment regimens recommended as part of the AASLD/IDSA simplified guidance Describe on-treatment monitoring for adults during HCV treatment using the simplified AASLD/IDSA guidance Describe appropriate post-treatment monitoring for adults after completing HCV treatment	Lesson 2Retreatment of Patients with Prior HCV Treatment Experience Discuss the approach to retreatment of patients with chronic hepatitis C in the direct-acting antiviral (DAA) era List the preferred therapeutic combinations for retreatment in persons with prior sofosbuvir-containing regimens Describe recommended options for retreatment in persons with prior treatment with elbasvir-grazoprevir Review preferred retreatment options for persons with prior treatment with glecaprevir-pibrentasvir Summarize options for persons with multiple prior DAA treatment failures	Lesson 3Monitoring During and After HCV Treatment List the recommended monitoring for treatment efficacy and safety in adults receiving HCV therapy Discuss monitoring for hepatitis B virus reactivation during HCV therapy Summarize the approach to persons with elevated alanine aminotransferase levels (ALT) during therapy Define sustained virologic response Describe appropriate monitoring for patients after HCV treatment	Lesson 4Treatment of HCV in Persons with Cirrhosis Distinguish persons with compensated cirrhosis from those with decompensated cirrhosis Summarize the impact of treating HCV in persons with cirrhosis Discuss major studies involving regimens with pangenotypic activity used to treat HCV in persons with compensated cirrhosis Provide appropriate HCV treatment options for persons with compensated cirrhosis List approaches to treatment of HCV in persons with decompensated cirrhosis	Lesson 5Treatment of Acute HCV Infection Discuss HCV epidemiologic features of acute hepatitis C virus (HCV) infection in the United States Explain spontaneous HCV clearance after acute infection and its impact on treatment strategies Formulate an approach to evaluate and treat persons with acute HCV infection Describe timing for initiating treatment of persons with acute HCV infection Summarize recommendations for treatment regimens for persons with acute HCV infection
Topic 1
Topic 2
Topic 3
Topic 4
Topic 5
Topic 6
Topic 7
Topic 8
Topic 9
Topic 10
CE Quiz

Self-Study Module Progress Tracker - 3rd Edition

3rd Edition. There is a newer edition of this Self-Study Module.

	Lesson 1Genotype 1 3rd Edition. There is a newer edition of this Lesson. This is your progress from the previous edition (3rd). List key factors that influence the choice and duration of therapy for treating HCV genotype 1 infection Describe the circumstances for NS5A genotypic drug resistance testing Discuss preferred therapies for initial treatment of treatment-naïve adults with HCV genotype 1 infection List the preferred therapies for retreatment of adults with chronic HCV genotype 1 infection who have previously failed therapy	Lesson 2Genotype 2 3rd Edition. There is a newer edition of this Lesson. This is your progress from the previous edition (3rd). List preferred therapies for initial treatment of adults with HCV genotype 2 chronic infection Describe the preferred therapy for retreatment of adults with HCV genotype 2 chronic infection who have failed prior therapy	Lesson 3Genotype 3 3rd Edition. There is a newer edition of this Lesson. This is your progress from the previous edition (3rd). List preferred therapies for initial treatment of adults with HCV genotype 3 chronic infection Describe the preferred therapy for retreatment of adults with HCV genotype 3 chronic infection who have failed prior therapy	Lesson 4Genotype 4 3rd Edition. There is a newer edition of this Lesson. This is your progress from the previous edition (3rd). Understand the preferred therapies for the initial treatment of adults with HCV genotype 4 chronic infection State the preferred therapy for retreatment of adults with HCV genotype 4 chronic infection in whom prior therapy has failed	Lesson 5Genotype 5 or 6 3rd Edition. There is a newer edition of this Lesson. This is your progress from the previous edition (3rd). List the preferred therapies for the initial treatment of adults with HCV genotype 5 or 6 chronic infection Discuss the preferred approach to retreatment of adults with HCV genotype 5 or 6 chronic infection who have failed prior therapy	Lesson 6Monitoring 3rd Edition. There is a newer edition of this Lesson. This is your progress from the previous edition (3rd). List the recommended monitoring for treatment efficacy and safety in adults receiving HCV therapy Discuss monitoring for hepatitis B virus reactivation during HCV therapy Summarize appropriate monitoring for patients after HCV treatment
Topic 1
Topic 2
Topic 3
Topic 4
Topic 5
Topic 6
CE Quiz

Self-Study Module Progress Tracker - 2nd Edition

2nd Edition. There is a newer edition of this Self-Study Module.

	Lesson 1Genotype 1 3rd Edition. There is a newer edition of this Lesson. This is your progress from the previous edition (3rd). List key factors that influence the choice and duration of therapy for treating HCV genotype 1 infection Describe the circumstances for NS5A genotypic drug resistance testing Discuss preferred therapies for initial treatment of treatment-naïve adults with HCV genotype 1 infection List the preferred therapies for retreatment of adults with chronic HCV genotype 1 infection who have previously failed therapy	Lesson 2Genotype 2 3rd Edition. There is a newer edition of this Lesson. This is your progress from the previous edition (3rd). List preferred therapies for initial treatment of adults with HCV genotype 2 chronic infection Describe the preferred therapy for retreatment of adults with HCV genotype 2 chronic infection who have failed prior therapy	Lesson 3Genotype 3 3rd Edition. There is a newer edition of this Lesson. This is your progress from the previous edition (3rd). List preferred therapies for initial treatment of adults with HCV genotype 3 chronic infection Describe the preferred therapy for retreatment of adults with HCV genotype 3 chronic infection who have failed prior therapy	Lesson 4Genotype 4 3rd Edition. There is a newer edition of this Lesson. This is your progress from the previous edition (3rd). Understand the preferred therapies for the initial treatment of adults with HCV genotype 4 chronic infection State the preferred therapy for retreatment of adults with HCV genotype 4 chronic infection in whom prior therapy has failed	Lesson 5Genotype 5 or 6 3rd Edition. There is a newer edition of this Lesson. This is your progress from the previous edition (3rd). List the preferred therapies for the initial treatment of adults with HCV genotype 5 or 6 chronic infection Discuss the preferred approach to retreatment of adults with HCV genotype 5 or 6 chronic infection who have failed prior therapy	Lesson 6Monitoring 3rd Edition. There is a newer edition of this Lesson. This is your progress from the previous edition (3rd). List the recommended monitoring for treatment efficacy and safety in adults receiving HCV therapy Discuss monitoring for hepatitis B virus reactivation during HCV therapy Summarize appropriate monitoring for patients after HCV treatment
Topic 1
Topic 2
Topic 3
Topic 4
Topic 5
Topic 6
CE Quiz

Self-Study Module Progress Tracker - 1st Edition

1st Edition. There is a newer edition of this Self-Study Module.

	Lesson 1Genotype 1 3rd Edition. There is a newer edition of this Lesson. This is your progress from the previous edition (3rd). List key factors that influence the choice and duration of therapy for treating HCV genotype 1 infection Describe the circumstances for NS5A genotypic drug resistance testing Discuss preferred therapies for initial treatment of treatment-naïve adults with HCV genotype 1 infection List the preferred therapies for retreatment of adults with chronic HCV genotype 1 infection who have previously failed therapy	Lesson 2Genotype 2 3rd Edition. There is a newer edition of this Lesson. This is your progress from the previous edition (3rd). List preferred therapies for initial treatment of adults with HCV genotype 2 chronic infection Describe the preferred therapy for retreatment of adults with HCV genotype 2 chronic infection who have failed prior therapy	Lesson 3Genotype 3 3rd Edition. There is a newer edition of this Lesson. This is your progress from the previous edition (3rd). List preferred therapies for initial treatment of adults with HCV genotype 3 chronic infection Describe the preferred therapy for retreatment of adults with HCV genotype 3 chronic infection who have failed prior therapy	Lesson 4Genotype 4 3rd Edition. There is a newer edition of this Lesson. This is your progress from the previous edition (3rd). Understand the preferred therapies for the initial treatment of adults with HCV genotype 4 chronic infection State the preferred therapy for retreatment of adults with HCV genotype 4 chronic infection in whom prior therapy has failed	Lesson 5Genotype 5 or 6 3rd Edition. There is a newer edition of this Lesson. This is your progress from the previous edition (3rd). List the preferred therapies for the initial treatment of adults with HCV genotype 5 or 6 chronic infection Discuss the preferred approach to retreatment of adults with HCV genotype 5 or 6 chronic infection who have failed prior therapy	Lesson 6Monitoring 3rd Edition. There is a newer edition of this Lesson. This is your progress from the previous edition (3rd). List the recommended monitoring for treatment efficacy and safety in adults receiving HCV therapy Discuss monitoring for hepatitis B virus reactivation during HCV therapy Summarize appropriate monitoring for patients after HCV treatment
Topic 1
Topic 2
Topic 3
Topic 4
Topic 5
Topic 6
CE Quiz